ArticleJCO global oncology2022

Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy.

Yehoda M Martei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.